Multipotent caudal neural progenitors derived from human pluripotent stem cells that give rise to lineages of the central and peripheral nervous system by Denham, Mark et al.
University of Wollongong
Research Online
Illawarra Health and Medical Research Institute Faculty of Science, Medicine and Health
2015
Multipotent caudal neural progenitors derived
from human pluripotent stem cells that give rise to
lineages of the central and peripheral nervous
system
Mark Denham
University of Melbourne, Aarhus University
Kouichi Hasegawa
Institute for Stem Cell Biology and Regenerative Medicine, Kyoto University
Trevelyan Menheniott
Murdoch Children's Research Institute
Benjamin Rollo
Murdoch Children's Research Institute
Dongcheng Zhang
Murdoch Children's Research Institute
See next page for additional authors
Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library:
research-pubs@uow.edu.au
Publication Details
Denham, M., Hasegawa, K., Menheniott, T., Rollo, B., Zhang, D., Hough, S., Alshawaf, A., Febbraro, F., Ighaniyan, S., Leung, J., Elliott,
D. A., Newgreen, D. F., Pera, M. F. & Dottori, M. (2015). Multipotent caudal neural progenitors derived from human pluripotent stem
cells that give rise to lineages of the central and peripheral nervous system. Stem Cells, 33 (6), 1759-1770.
Multipotent caudal neural progenitors derived from human pluripotent
stem cells that give rise to lineages of the central and peripheral nervous
system
Abstract
The caudal neural plate is a distinct region of the embryo that gives rise to major progenitor lineages of the
developing central and peripheral nervous system, including neural crest and floor plate cells. We show that
dual inhibition of the glycogen synthase kinase 3β and activin/nodal pathways by small molecules
differentiate human pluripotent stem cells (hPSCs) directly into a preneuroepithelial progenitor population
we named "caudal neural progenitors" (CNPs). CNPs coexpress caudal neural plate and mesoderm markers,
and, share high similarities to embryonic caudal neural plate cells in their lineage differentiation potential.
Exposure of CNPs to BMP2/4, sonic hedgehog, or FGF2 signaling efficiently directs their fate to neural crest/
roof plate cells, floor plate cells, and caudally specified neuroepithelial cells, respectively. Neural crest derived
from CNPs differentiated to neural crest derivatives and demonstrated extensive migratory properties in vivo.
Importantly, we also determined the key extrinsic factors specifying CNPs from human embryonic stem cell
include FGF8, canonical WNT, and IGF1. Our studies are the first to identify a multipotent neural progenitor
derived from hPSCs, that is the precursor for major neural lineages of the embryonic caudal neural tube.
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Rise to Lineages of the Central and Peripheral
Nervous System
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ABSTRACT
The caudal neural plate is a distinct region of the embryo that gives rise to major progenitor line-
ages of the developing central and peripheral nervous system, including neural crest and floor
plate cells. We show that dual inhibition of the glycogen synthase kinase 3b and activin/nodal
pathways by small molecules differentiate human pluripotent stem cells (hPSCs) directly into a
preneuroepithelial progenitor population we named “caudal neural progenitors” (CNPs). CNPs
coexpress caudal neural plate and mesoderm markers, and, share high similarities to embryonic
caudal neural plate cells in their lineage differentiation potential. Exposure of CNPs to BMP2/4,
sonic hedgehog, or FGF2 signaling efficiently directs their fate to neural crest/roof plate cells, floor
plate cells, and caudally specified neuroepithelial cells, respectively. Neural crest derived from
CNPs differentiated to neural crest derivatives and demonstrated extensive migratory properties
in vivo. Importantly, we also determined the key extrinsic factors specifying CNPs from human
embryonic stem cell include FGF8, canonical WNT, and IGF1. Our studies are the first to identify a
multipotent neural progenitor derived from hPSCs, that is the precursor for major neural lineages
of the embryonic caudal neural tube. STEM CELLS 2015;33:1759–1770
INTRODUCTION
In the embryo, specification of early neural pro-
genitors begins soon after gastrulation with the
formation of the neural plate, which subse-
quently folds to become the embryonic neural
tube [1, 2]. The embryonic neural plate can be
divided into two developmentally distinct
regions, the rostral (anterior) and caudal (poste-
rior) neural plates. Specification of the rostral
neural plate occurs during the earliest stages of
neural induction and gives rises to the rostral
forebrain, which corresponds to the telencepha-
lon and rostral diencephalon. The caudal neural
plate gives rise to the caudal diencephalon,
mesencephalon, and metencephalon and the
spinal cord. Lineages associated with the caudal
neural plate include ventral floor plate cells,
dorsal roof plate cells, and neural crest.
Formation of the caudal neural plate is
mediated by caudalizing signals, such as Wnts,
retinoic acid, and FGF, secreted from the primi-
tive streak and caudal mesoderm [1, 3]. Recent
studies have demonstrated that the caudal neu-
ral plate region arises from bipotent mesoecto-
dermal progenitors, also known as axial stem
cells, which coexpress mesodermal and neural
markers including Sox2 and Brachyury [4, 5].
Axial stem cells can generate either neural or
mesodermal lineages, their fate being regulated
by persistent expression of Sox2 or onset of
Tbx6 expression, respectively [4, 6].
The earliest neural marker associated with
the human neural plate has been demon-
strated to be PAX6 [7] and the derivation of
PAX6 neural progenitor from human pluripo-
tent cultures reveals a rostral identity which
can be achieved by dual SMAD inhibition [8].
Exposing these rostral neural plate progeni-
tors to caudalization cues has previously been
reported to shift these neural progenitors
into a caudal identity [9]. However, to date,
the direct derivation of an early caudal neural
progenitor that can generate multiple caudal
neural plate derivatives has not been
demonstrated.
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Our previous studies described the derivation of an early
neural progenitor cells derived from human pluripotent stem
cell (hPSC), phenotypically defined as OCT42/SOX21/PAX62
[10]. These progenitors are generated by 4 days treatment of
hPSC with small molecule inhibitors of glycogen synthase
kinase 3b (GSK3b) and Activin/Nodal signaling, called
CHIR99021 (CHIR) and SB431542 (SB), respectively. Subse-
quent removal of the dual inhibitors results in the upregula-
tion of the neuroepithelial marker, PAX6 [10]. Our studies also
showed that activating the sonic hedgehog (SHH) pathway in
these OCT42/SOX21/PAX62 progenitors results in their effi-
cient differentiation to FOXA21 floor plate cells, a major deriv-
ative of the caudal neural plate [10]. Here, we further
characterize the OCT42/SOX21/PAX62 progenitors and dem-
onstrate their coexpression of mesodermal and caudal neural
markers, and biased differentiation toward neural lineages of
the caudal neural plate. Consistent with a caudal neural plate
identity, we also show their efficient capacity to be directed to
neural crest lineages. Given their phenotypic characteristics, we
have renamed and further defined the OCT42/SOX21/PAX62
progenitors as “caudal neural progenitors” (CNPs). Finally, we
determined the extrinsic signaling factors that can mediate CNP
induction from hPSC are FGF8, canonical WNT, and IGF1. In
summary, these studies describe a novel multipotent progenitor
lineage derived from hPSCs, which are the precursor cells for
caudal neural plate lineages, and identify the signaling path-
ways involved in inducing CNP fate.
MATERIALS AND METHODS
Human Embryonic Stem Cell Culture
HES-3 (WiCell, Madison, WI, www.wicell.org), ENVY-HES-3 (Bio-
Time, Alameda, CA, USA, www.biotimeinc.com), Mixl-green
fluorescent protein (GFP) HES [11], H9 (WA-09, WiCell), and
iPS (Foreskin)21 (WiCell) cell lines were cultured as previ-
ously described [12]. Briefly, human embryonic stem cells
(hESCs) and hiPSCs were cultured on mitomycin-C treated
human foreskin fibroblasts (HFF) in knock serum replacer
(KSR) media consisting of Dulbecco’s modified Eagle’s medium
(DMEM)/nutrient mixture F-12, supplemented with b-
mercaptoethanol 0.1 mM, nonessential amino acids 1%, gluta-
mine 2 mM, penicillin 25 U/ml, streptomycin 25 mg/ml, and
knockout serum replacement 20% (all from Life technologies,
Mulgrave, Australia, www.lifetechnologies.com). All cells were
cultured at 37C 5% CO2. Colonies were mechanically dis-
sected every 7 days and transferred to freshly prepared HFFs.
Media was changed every second day.
Neural Induction in Defined Medium
hESCs or hIPSCs were mechanically dissected into pieces
approximately 0.5 mm in diameter and transferred to laminin-
coated organ culture plates in N2B27 medium containing 1:1
mix of neurobasal medium with DMEM/F-12 medium, supple-
mented with insulin/transferrin/selenium 1%, N2 1%, retinol-
free B27 1%, glucose 0.3%, penicillin 25 U/ml, and streptomy-
cin 25 mg/ml (all from Life Technologies) for 11 days [13].
SB431542 (SB; 10 mM, Tocris Bioscience, Bristol, UK, www.tocris.
com) was added to the media only for the first 4 days followed
by the addition of FGF2 (20 ng/ml, R&D) from days 4 to 11.
Cultures were grown on laminin for the first 4 days after which
they were dissected into 0.5 mm pieces and cultured in suspen-
sion in low-attachment 96-well plates (Corning, Corning, NY,
USA, www.corning.com) in N2B27 medium.
For CNP induction, neural induction was performed as
above and cultures were supplemented with GSK3b inhibitor
CHIR99021 (CHIR; 3 mM, Stemgent, Cambridge, MA, USA,
www.stemgent.com) from days 0 to 4. For neural crest specifi-
cation, CNP induction was performed and from days 4 to 11
cultures were supplemented with FGF2 and BMP2 (50 ng/ml;
Peprotech, Rehovot, Israel, www.peprotech.com). For floor
plate specification, CNP induction was performed and supple-
mented with the Smoothened agonist (SAG; 400 nM, Merck,
Kenilworth, NJ, USA, www.merck.com) from days 0 to 11,
from days 4 to 11 cultures were also supplemented with
FGF2. For neuronal differentiation of neural crest progenitors
cultures were differentiated to neural crest progenitors by day
11, at which time BMP2 was removed and cultures were sup-
plemented with small molecule Rho kinase inhibitor Y27632
(25 mM; Tocris) from days 11 to 18.
For adipocyte, chondrocyte, and osteocyte differentiation,
day 11 neural crest progenitors were dissociated with Accu-
tase (Life Technologies) and plated cultured in DMEM 10%
FCS medium supplemented with Y27632 (25 mM; Tocris) for 1
week followed by 2 weeks in either: StemPro adipogenesis
medium, chondrogenesis medium, or osteogenesis medium
(all from Life Technologies).
To determine pathways mediating induction of CNPs, induc-
tion was performed in N2B27 medium with SB from days 0 to
4 and instead of CHIR various combinations of the following
factors were supplemented: FGF8b (100 ng/ml, R&D Systems,
Minneapolis, MN, USA, www.rndsystems.com), IGF1 (20 ng/ml,
Peprotech), Wnt3A (100 ng/ml, Peprotech), MEK1/2 inhibitor
PD0325901 (PD; 1 mM, Tocris), inhibitor of phosphatidylinositol
3-kinase (PI3K), and LY294002 (LY; 20 mM, Tocris). Differentia-
tion of these factor conditions toward floor plate or roof plate
culture was achieved by removing the factors at day 4 and
extending the cultures in the following two ways: For floor
plate specification SAG was added to cultures from days 0 to
11 and FGF2 from days 4 to 11. For neural crest specification,
BMP2 and FGF2 were added to cultures from days 4 to 11.
Where indicated, cultures were supplemented with either:
Smoothened agonist (SAG; 400 nM, Merck), FGF8, Wnt3A IFG1
(20 ng/ml, Peprotech), PD (1 mM, Tocris), and LY (20 mM, Toc-
ris). Diagrams of conditions are shown in relevant figures.
Mesoderm Induction Assay
HES cells were grown on laminin for the first 4 days in N2B27
medium supplemented with CHIR and SB as described above,
after which they were cultured in either APEL media (Stemcell
Technologies, Tullamarine, Australia, www.stemcell.com) [14]
or N2B27 medium, with and without supplementation with
FGF2 (20 ng/ml) only, or BMP4 (20 ng/ml)/Activin A (20 ng/
ml)/FGF (10 ng/ml), or Activin A (20 ng/ml)/FGF2 (10 ng/ml)
for an additional 4–11 days.
In Ovo Transplantation
Fertilized quail (Coturnix coturnix japonica) eggs were
obtained from Lago Game Supplies, Vic., Australia. Fertilized
chick (Gallus gallus) eggs were obtained from Research Hatch-
ery, Vic., Australia. Embryos were staged according to the
number of embryonic days (E), Hamburger and Hamilton
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stages (HH) [15] and, for embryos of E2.5 and younger, by
somite counts. Day 11 CNP-derived neural crest progenitors
or CNP-derived neuroepithelial progenitors were mechanically
dissected into small fragments up to the size of an E2 quail
somite (200-mm diameter or less). With use of techniques
identical to chick-quail grafting [16], the fragments were
implanted into quail embryos in ovo. For implants next to
trunk NT and for vagal level implants E2 (17–20 somite) and
E1.5 (7–8 somite) embryos were used, respectively. Electrolyti-
cally sharpened 0.25 mm diam. tungsten needles were used
to create a slit in which the fragments were inserted.
Gut migration assays were performed by placing CNP-
derived neural crest progenitors at the rostral end of E4.5
(HH25) quail mid/hindguts assembled on 5 3 5 mm2 of
ethanol-sterilized black Millipore HA paper. These were
inverted tissue-side down on the chorio-allantoic membrane
(CAM) of 9-day chick embryos and grown for 7 days as previ-
ously described [17]. Grafts were then retrieved and dissected
free of CAM tissues.
Temporal Gene Expression Analysis
Total RNA was isolated from individual wells of cells using the
RNeasy Micro kit (Qiagen, Chadstone Centre, Australia, www.
qiagen.com). Equivalent amounts of total RNA were reverse
transcribed using the Quantitect RT kit (Qiagen). Resulting cDNA
was then preamplified in multiplex format using gene-specific
primer sets (Supporting Information Methods) prior to qPCR
analysis on microfluidic chips. Multiplex pre-amp reactions con-
sisted of 2.5 ml Taqman Preamp Master Mix (ABI, Life Technolo-
gies), 1.25 ml of a 0.23 concentration of pooled Taqman primer
sets in TE buffer, and 1.25 ml of cDNA. Preamp cycling condi-
tions were 95C for 10 minutes, followed by 16 cycles each at
95C for 15 seconds followed by 60C for 4 minutes. Reactions
were stopped by heating at 99.9C for 10 minutes. Preamplified
samples were diluted 1:5 with Tris-EDTA (TE) buffer prior to
qPCR analysis. Single gene-specific qPCR reactions using individ-
ual Taqman primer sets (Supporting Information Methods) were
carried out on a Biomark HD instrument using 48 3 48
Dynamic Array Gene Expression microfluidic chips (Fluidigm,
South San Francisco, USA, www.fluidigm.com). Prior to loading
onto the chip, individual TaqMan gene expression assays (203)
were diluted 1:1 with 23 assay loading reagent (Fluidigm). Pre-
amplified samples (2.75 ml) were combined with 2.5 ml TaqMan
Universal Master Mix (ABI) and 0.25 ml 203 GE sample loading
reagent (Fluidigm). qPCR cycling conditions were 50C for 2
minutes, 95C for 10 minutes, followed by 40 cycles each at
95C for 15 seconds followed by 60C for 1 minute.
Gene Expression Analysis at Neural Progenitor States
hESC, day 4 and day 11 time points of the various differentiation
conditions were collected by mechanical isolation, all conditions
were analyzed from three independent biological replicates.
Total RNA was isolated from cells using the RNeasy Mini RNA
Extraction Kit (Qiagen) and contaminant genomic DNA removed
with DNA-free DNaseI reagents (Ambion, Life Technologies).
Primer sequences were designed using the primer3 tool (http://
frodo.wi.mit.edu/primer3/). For quantitative reverse transcrip-
tion and polymerase chain reaction (Q-PCR), oligo-dT primed
cDNA was synthesized from 130 ng DNaseI-cleaned total RNA
using Murine Moloney Leukemia Virus reverse transcriptase
(Promega, Alexandria, Australia, www.promega.com). Q-RTPCR
was performed on an ABI Prism 7500 Fast Real-Time PCR System
(Applied Biosystems, Life Technologies) using Go-Taq SYBR green
master mix (Promega). Relative gene expression values (mRNA
fold change) were obtained by normalization to the internal
reference genes RPL32 using the 22DDCt method, where
22DDCt5DCt sample2DCt calibrator as described [18]. Hier-
archical clustering and heatmap analysis of Q-PCR data were
done using R-script and gplots packages.
Fluorescent-Activated Cell Sorting Analysis
hESCs or differentiated derivatives were dissociated into single
cells with TrypLE Express (Life Technologies) centrifuged and
resuspended in 4% paraformaldehyde (PFA) for 10 minutes and
subsequently washed in phosphate buffered saline (PBS) and
permeabilized with 0.25% Triton X in PBS (PBT). Goat anti-Sox10
(1:20, R&D Systems) antibody was diluted in blocking solution
(PBT with 10% fetal calf serum (FCS)) and cells were centrifuged
and resuspended in antibody solution overnight at 4C. Follow-
ing three 10-minute washes in PBT, cells were resuspended in a
donkey anti-goat Cy5 (1:400, Jackson ImmunoResearch, West
Grove, PA, USA, www.jacksonimmuno.com) antibodies for 30
minutes at RT, followed by a wash in blocking solution before
being sorted using an LSR Fortessa cell analyzer.
Immunolabeling
Cell monolayers and neurospheres were fixed in 4% PFA for 20
minutes at 4C and then washed briefly in PBS. Neurospheres
were embedded in Tissue-Tek OCT compound (Labtech, Wind-
sor, Australia, www.labtech.com.au), cut at 10 mm on a cryo-
stat, and sections were placed on superfrost slides. Sections or
culture dishes were blocked for 1 hour at room temperature
(RT) in blocking solution. The following primary antibodies
were used: goat anti-SOX10 (1:100, R&D Systems), goat anti-
FoxA2 (1:300, Santa Cruz Biotechnology, Dallas, Texas, USA,
www.scbt.com), goat anti-Sox2 (1:500, R&D), mouse anti-Sox2
(1:500 R&D), mouse anti-Oct4 (1:100, Santa Cruz), mouse anti-
Tuj1 (1:500, Promega), mouse anti-Pax3 (1:40, Developmental
Studies Hybridoma Bank, Iowa City, Iowa, USA, www.dshb.biol-
ogy.uiowa.edu), mouse anti-Pax7 (1:40, DSHB), mouse anti-AP2
(1:100, DSHB), mouse anti-Pax6 (1:40, DSHB), mouse anti-PRPH
(1:500, Millipore Merck), mouse anti-Brn3a (1:500, Millipore),
rabbit anti-Islet1 (1:500, Abcam, Melbourne, Australia, www.
abcam.com), rabbit anti-HOXB1 (1:500 Abcam), mouse anti-
S100b (1:500, Sigma-Aldrich, Sydney, Australia, www.sigmaal-
drich.com), mouse anti-HuC/D (1:100, Invitrogen/Molecular
Probes), mouse anti-NAPA-73 (1:200, E/C8, DSHB), rabbit anti-
p75 (1:500, Promega), rabbit anti-SoxE (1:2,000, Craig Smith,
MCRI), goat anti-BRACHYURY (1:100, R&D Systems), goat anti-
TBX6 (1:100, R&D Systems), and rabbit anti-Lmx1A (1:5,000,
Millipore). Antibodies were diluted in blocking solution incu-
bated on sections overnight at 4C. Following three 10-minute
washes in PBT, the corresponding Cy5, DyLight-488, or DyLight-
594 donkey secondary antibodies were applied for 1 hour
(overnight for CAM grafts) at RT (1:400, Jackson ImmunoRe-
search). Sections and cultures were counterstained with 40,6-
diamidino-2-phenylindole (DAPI; 1 mg/ml, Sigma). Slides were
mounted in PVA-DABCO for viewing under a fluorescent micro-
scope (Olympus Life Science, Notting Hill, Australia, www.olym-
pus-lifescience.com), and images captured using the Cell-M
software. Confocal microscopy was performed using an Olym-
pus FV1000 Confocal Microscope. The image was then
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reconstructed as an intensity projection over the z-axis using
Olympus FV10-ASW 2.0 Viewer software.
Adipocyte, Chondrocyte, and Osteocyte Staining
Alcian blue, oil red O, and alizarin red S staining were performed
according to standard protocols using Alcian blue, 8GX (Sigma),
oil red O (Sigma), and Alizarin Red S (Sigma), respectively.
Statistical Analysis
Fluorescent activated cell sorting (FACS) analysis was performed
on at least 10,000 events per replicate. These events were
counted after gating out cell debris and doublets on the forward
and side scatter. For QPCR and FACS analysis, experiments were
repeated at least three times. One-way ANOVAs or t tests were
performed for statistical analyses. Quantification of SOX2/BRA-
CHYURY, PAX6, LMX1A, SOX10, or FOXA2-positive cells was per-
formed on cryostat sections. Cells were stained for their
respective markers and the percentage of positive cells was calcu-
lated using random sampling of cryostat sections from the aggre-
gates. DAPI nuclei and positive nuclei were counted using image
J analysis with Image-based Tool for Counting Nuclei software.
RESULTS
Temporal Gene Expression Changes of
SB/CHIR-Treated hPSCs
Our previous studies described a novel OCT42/SOX21/
PAX62 progenitor derived from hPSC, which is induced by
dual inhibition of the GSK3b and Activin/Nodal pathways medi-
ated by CHIR and SB treatments, respectively [10]. To further
characterize the transition from pluripotency to this progenitor
state, we performed temporal Q-PCR analyses of pluripotent
and early lineage markers on hPSC treated with SB and CHIR
(treatment: SB/CHIR) for 4 days (Fig. 1). This data were com-
pared to hPSC treated with SB only (treatment: SB). We found
that within 4 days of SB/CHIR or SB treatments, there was a
dramatic and robust decrease in pluripotent gene transcripts,
OCT4 (p <.0005), NANOG (p <.05), and DNMT3B (SB p <.05,
SB/CHIR p <.005). Additional pluripotent markers, C-MYC and
FOXD3, were also significantly decreased in the SB/CHIR group
by day 4 (p <.005). SOX2 transcript levels remained relatively
unchanged in the SB/CHIR group across the 4 days, although
they were significantly increased in the SB group relative to
both hPSC (day 0) and day 4 SB/CHIR treatments (p <.05).
As expected, rostral neuroepithelial markers, PAX6 (p
<.05), SOX3 (p <.005), FOXG1 (p <.0005), SIX3 (p <.05), and
ZNF521 (p <.005), were all significantly increased in the SB
only conditions when compared to the pluripotent stem cell
state (Fig. 1). In contrast, expression of rostral neuroepithelial
markers was not upregulated in the SB/CHIR conditions, but
instead there was a significant increase in the caudal neural
marker, GBX2 (p <.05) and persistent expression of SOX2.
Other genes involved in neural induction, Noggin (NOG) (p
<.05) and NCAM (p <.05), were also found to be significantly
upregulated in the SB/CHIR conditions compared to the pluri-
potent state. Interestingly, SB/CHIR treatment also showed
transient upregulated expression of MIXL1 at day 2 (p <.005)
and persistent and massive upregulated expression of BRA-
CHURY at day 4 (p <.05), both of which are mesoderm line-
age markers. Furthermore, SB/CHIR treatment showed
coexpression of SOX2/BRACHURY in 97.66% (60.57 SD) of
cells at day 4 (Fig. 1B). The combined expression of caudal
neural plate and mesoderm markers in the SB/CHIR condi-
tions suggests the SB/CHIR-treated hPSCs may be similar to
the axial stem cells found in the caudal lateral epiblast region
of mouse and avian embryos that have the bipotential to give
rise to both neural and mesodermal lineages [4].
SB/CHIR-Treated hPSCs Show Biased Differentiation to
Caudal Neural Progenitor Lineages
Expression analyses of the SB/CHIR-treated hPSCs described
above showed coexpression of mesoderm and caudal neural
progenitor markers. We therefore investigated the potential of
SB/CHIR-treated hPSCs to differentiate to mesodermal progen-
itor lineages. These experiments were performed using the
mesoderm reporter MIXL-GFP hESC line [11] as well as H9
cells. Following 4 days SB/CHIR treatment, cells were further
cultured in media only or media supplemented with BMP4
and Activin A, or Activin A only, to support mesoderm differ-
entiation. Immunostaining analyses of the SB/CHIR aggregates
in all differentiation conditions showed no expression of the
mesoderm markers, BRACHYURY and TBX6 (data not shown).
Although very few GFP1 cells were observed in some of the
aggregates, these tended to correspond to apoptotic nuclei
(Supporting Information Fig. S1). In contrast, high expression
of SOX21/PAX61 rosettes was observed (Supporting Informa-
tion Fig. S1). This suggests that the SB/CHIR-treated hPSCs are
biased toward differentiating to neural lineages despite show-
ing expression of mesodermal markers.
We have shown that neural differentiation of SB/CHIR-
treated hPSCs results in upregulated expression of PAX6 [10].
In the embryo, PAX6 is expressed in both the telencephalon and
diencephalon regions of the developing forebrain, which
includes the prospective prosomeres 1 and 2 domains that arise
from the caudal neural plate [19, 20]. We therefore sought to
determine whether neural differentiation of SB/CHIR-treated
hPSCs gives rise to neural progenitors that are phenotypic of the
rostral or caudal neural plate derivatives. For these analyses, day
4 SB/CHIR-treated cells were further differentiated for 7 days in
FGF-supplemented neural basal media as previously described
[10]. Following neural differentiation, Q-PCR analyses showed
significantly high expression of caudal neural tube markers IRX3,
GBX2, HOXB1 as well as PAX6 (Fig. 2) [21–23]. By immunofluo-
rescence HOXB1 was detected in SB/CHIR-treated cells at day4
and following 7 days in FGF, PAX6/IRX3-positive cells were
detected (Fig. 2C). In contrast, no increased expression of rostral
neural tube markers, FOXG1 and SIX3, was observed (Fig. 2; Sup-
porting Information Fig. S2) [24–26]. Although OTX1 and OTX2
are expressed in the forebrain and midbrain regions of the
developing embryo [27, 28], their expression was not signifi-
cantly changed in the SB/CHIR or SB/CHIR-FGF-treated cells
(Fig. 2; Supporting Information Fig. S2). This discrepancy may be
partly explained by the expression of OTX2 in undifferentiated
hESC [29]. Given the caudal neural identity of SB/CHIR-treated
hPSCs and their neural derivatives, we have coined this progeni-
tor population as CNPs.
Derivation of Neural Crest and Roof Plate Progenitors
from CNPs
The embryonic caudal neural plate gives rise to floor plate,
roof plate, and neural crest progenitors. We have previously
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described generation of floor plate cells from CNPs (previously
called “pre-neuroepithelial”) [10]. Furthermore, neural differ-
entiation of CNPs gives rise to neuronal progenitors express-
ing caudal neural tube markers (Fig. 2). Taken together, we
hypothesized that CNPs share characteristics to the embryonic
neural plate and may therefore also be capable of differentiat-
ing to neural crest progenitors given the appropriate signals.
To investigate this, we treated CNPs derived from hPSC with
either BMP2 or FGF2 for 7 days (treatments SB/CHIR-BMP
and SB/CHIR-FGF, respectively). After 7 days, aggregate cul-
tures were analyzed for expression of neural crest and neuro-
epithelial markers by immunostaining (Fig. 3), Q-PCR (Fig. 3),
and FACS (Supporting Information Fig. S3). The BMP-treated
CNPs showed a significantly higher percentage of the early
neural crest marker SOX10 by FACS analysis (53.98%6 7.72%
SEM, p <.005) compared with FGF-treated CNPs
(5.23%6 0.65% SEM) (Supporting Information Fig. S2). By Q-
PCR analysis BMP-treated CNPs also showed significantly
Figure 1. Temporal gene expression analysis comparing SB versus SB/CHIR from pluripotency. QPCR analysis of SB versus SB/CHIR from
day 0 to day 4. (A): Mean (6SD) ANOVA with Tukey’s multiple comparisons were performed. *, p <.05; **, p <.005; ***, p <.0005.
Blue stars represent comparison of SB/CHIR to day 0, red stars represent difference between SB to day 0. Black stars represent compari-
son between SB and SB/CHIR. Not all significant differences are shown. (B): Immunocytochemistry analysis of SB/CHIR at day 4 for SOX2
and BRACYURY. Scale bars5 100 mm.
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higher expression of the early neural crest markers, SOX10 (p
<.0001), AP2 (p <.005), and FOXD3 (p <.001), when com-
pared with FGF-treated CNPs. By immunofluorescence, AP2,
PAX3, and PAX7 were detected only in BMP-treated CNPs (Fig.
3). Of note, PAX3 and PAX7 are markers of the embryonic dor-
sal neural tube [30, 31]. Q-PCR data show that upregulated
expression of neural crest markers occurs after, and not prior
to, BMP-treatment of CNPs (Fig. 3D). In contrast, FGF2-
Figure 2. Gene expression analysis of SB/CHIR-derived neuroepithelial progenitors at day 11. (A): Diagram showing gene expression
domains along the rostral-caudal axis of the mouse embryonic neural tube [13–22]. The rostral neural plate gives rise to the Tel and Ros
Di, whereas the caudal neural plate gives rise to the Cau Di, Mes, and Met regions of the neural tube. The ZLI region corresponds to
the boundary dividing the anterior and caudal neural plate derivatives. (B): Two-way hierarchical clustering of QPCR data for the follow-
ing genes: IRX3, GBX2, HOXB1, PAX6, FOXG1, SIX3, OTX2 against treatment conditions: day 4 SB/CHIR and day 11 SB/CHIR-FGF. The heat-
map shows log 10 mRNA fold change values relative to undifferentiated hESCs; upregulated and downregulated genes are colored red
and green, respectively. (C): Immunocytochemistry analysis of SB/CHIR at day 4 for HOXB1 and SB/CHIR-FGF at day 11 for PAX6 and
IRX3. Scale bars5 100 mm. Abbreviations: Cau Di, caudal diencephalon; Mes, mesencephalon; Met, metencephalon; Ros Di, rostral dien-
cephalon; Tel, telencephalon; ZLI, zona limitans intrathalamica.
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treated CNPs showed almost no upregulated expression of
neural crest and dorsal neural tube markers compared with
hESC (Fig. 3D). However, significantly higher expression and
percentage of PAX6 were calculated in the FGF-treated CNPs
(5.29%6 1.69% SD) compared to the BMP-treated
(36.92%6 9.44% SD) conditions (p <.001; Fig. 3D). Overall,
this data demonstrate that exposure of CNPs to BMP proteins
specifies their fate to a neural crest lineage at the expense of
a PAX61 neuroepithelial cell lineages.
Duration of BMP Treatment Is Important for Neural
Crest Induction
To further determine whether the duration of BMP exposure
is important to induce neural crest fate, FGF-treated CNPs
were exposed to BMP2 treatment for a further 7 days in cul-
ture (treatment: SB/CHIR-FGF-BMP). Interestingly, delayed
exposure to BMP2 caused the expression of the dorsal neural
tube marker, PAX3 (Fig. 4C), but a significantly lower percent-
age of SOX10 2.05% (61.46 SEM; p <.0001), compared to
day 11 BMP-treated CNPs (treatment: SB/CHIR-BMP) (Fig. 4B).
This indicates that, similar to the floor plate, hPSC induction
of neural crest efficiently occurs prior to their differentiation
to PAX61 neuroepithelial cells.
Characterization of hPSC-Derived Neural Crest
Characteristic functional features of neural crest include their
ability to migrate and differentiate to peripheral neurons and
non-neural lineages. Progenitors derived from BMP-treated
CNPs were further differentiated to neurons and glia in vitro
(Fig. 5). Neuronal cultures showed extensive outgrowth of
Peripherin1 (PRPH) neurites and also high coexpression of sen-
sory neural progenitor markers, BRN3A and ISLET1 (Fig. 5A)
[32]. Evidence of Schwann cell differentiation was also
observed in glial differentiated cultures, with colocalized
expression of p75 and S100b (Fig. 5C). BMP-treated CNPs were
also capable of differentiating to mesenchymal lineages, carti-
lage, adipose, and osteoblasts (Fig. 5D). To assess migration,
BMP-treated CNPs were transplanted beside the embryonic
neural tube of avian embryos in ovo. Three to five days post-
transplantation, robust migration of donor cells was observed
streaming along endogenous neural crest pathways (Fig. 6A–
6F). This migration occurred even in the absence of endoge-
nous neural crest cells (Fig. 6E). Donor GFP1 cells were also
localized in regions of peripheral neurons, including the dorsal
root ganglia and sympathetic ganglia, and although they were
not positive for neuronal markers, they coexpressed SOX10 sug-
gesting they were delayed in their differentiation (Fig. 6B, 6D,
6E). In addition, when BMP-treated CNPs progenitors were
placed abutting E4 quail mid/hindgut and grown for 7 days in
CAM graft, donor GFP1 cells migrated into the gut (Fig. 6F). In
contrast, in ovo transplants of SB/CHIR-FGF progenitors
remained as tight rosette-shaped aggregates within the implant
(Fig. 6G). Taken together, BMP-treated CNPs demonstrate in
vitro and in vivo properties of bona fide neural crest.
Figure 3. Caudal neural progenitors give rise to neural crest progenitors. (A): Diagram of culture conditions. (B): Immunocytochemistry
analysis of SB/CHIR-BMP at day 11 for LMX1A, SOX10, PAX3, PAX7, AP2, and PAX6. (C): Immunocytochemistry analysis of SB/CHIR-FGF at
day 11 for LMX1A, SOX10, PAX6, PAX3, and AP2. (D): QPCR analysis of SOX10, AP2, FOXD3, and PAX6 at; the pluripotent stage—H9
hESC; day 4 SB/CHIR; day 11 SB/CHIR-BMP; day 11 SB/CHIR-FGF. Mean6 SD, n5 3, ANOVA with Tukey’s multiple comparisons was per-
formed. **, p <.005; ***, p <.0005. Scale bars5 100 mm.
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BMP2-Treated CNPs Show Properties of Roof Plate
Cells
Given that neural crest is derived from the neural folds of the
embryo, and these border regions eventually gives rise to the
roof plate of the neural tube, we proposed that the BMP-
treated CNPs aggregates consisted of roof plate cells as well
as neural crest progenitors. Indeed, 1.45% (60.45 SD) of cells
in the BMP-treated CNP spheres expressed LMX1A, a marker
of roof plate (Fig. 3B). In contrast, significantly fewer LMX1A1
cells were observed in the FGF-treated conditions (0.17%;
60.05 SD; p <.01; Fig. 3C). To further assess this hypothesis,
expression of dorsalizing morphogens was analyzed in the day
4 CNPs, and BMP-treated and FGF-treated CNPs. Significantly
higher expression of WNT1 and WNT3A was observed in the
BMP-treated CNPs group relative to hPSC (p <.005), but not
in CNPs (Supporting Information Fig. S4). The FGF-treated
CNPs also showed an increased expression of WNT1 (p <.05),
although this increase was relatively lower than the BMP
treatment (Supporting Information Fig. S4). In contrast, FGF-
treated CNPs showed no significant increase in WNT3A
expression. A significant downregulation of BMP 2/4 was
observed in both BMP-CNPs and FGF-CNPs samples (p <.05),
although this is cofounded by the fact that BMP2/4 are highly
expressed in undifferentiated hPSC (S. Hough, unpublished
data). This data suggest that the BMP-treated CNPs secrete
WNTs as dorsalizing signals similar to the embryonic roof
plate [33], and thus, similar to the floor plate, these cells are
also specified temporally and/or spatially different to PAX6
neuroepithelial cells.
Pathways Mediating Induction to a CNP State
Small molecule inhibition of GSK3b may activate many dif-
ferent intracellular pathways including, canonical Wnt, and
IGF signaling [34]. To identify the specific pathways
involved in the neural induction of CNPs, we examined
whether extrinsic factors known to be involved in embry-
onic neural induction could mimic or replace GSK3b
Figure 4. Neural crest specification is restricted to the caudal neural progenitor state. (A): Diagram of culture conditions. (B): Quantifi-
cation of SOX10-positive cell between day 11 SB/CHIR-BMP condition and day 18 SB/CHIR-FGF-BMP condition (mean6 SEM, n5 3, t
test, ***, p <.0001). (C): Immunocytochemistry analysis of SB/CHIR-FGF-BMP at day 18 for, SOX10, PAX6, AP2, and PAX3. Scale
bars5 100 mm.
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inhibition by CHIR. hPSCs were treated with the small molecule
inhibitor SB together with different combinations of Wnt3a,
FGF8, and IGF for 4 days. Each of these conditions was then
exposed to either SAG (a small molecule agonist of the SHH
pathway) or BMP2 for a further 7 days, to induce their fate
toward floor plate or neural crest, respectively. Proportion of
cells expressing SOX21/OCT42/PAX62 was observed to be
the highest at day 4 when all three factors (Wnt3a, FGF8, and
IGF) were present (Fig. 7B). Furthermore, these conditions gave
rise to significantly higher FOXA2 expression when treated with
SAG (Fig. 7C) and significantly higher SOX10 expression when
treated with BMP2 (Fig. 7D). Omission of FGF8 showed similar
results, although floor plate induction was reduced. Floor plate
or neural crest induction was significantly reduced or abolished
if IGF1 and/or Wnt3a were omitted. These results were further
supported using small molecule inhibitors of the PI3K pathway
(LY294002) and MEK1/2 pathway (PD0325901), which block
IGF1 and FGF signaling, respectively [35–37]. Taken together,
these results show that hPSC induction to CNPs is mediated by
the canonical Wnt, IGF1, and FGF8 pathways.
DISCUSSION
These studies describe a novel progenitor type derived from
hPSC that shows many similarities to the embryonic caudal
neural plate. These CNPs can be derived directly from a pluri-
potent state through the small molecule inhibition of GSK3b
and Activin/Nodal signaling. CNP progenitors are a pivotal point
for determining cell fate to roof plate/neural crest, floor plate,
and caudal neuroepithelial progenitors depending on the mor-
phogenetic signal. The key gene expression profile that defines
CNPs is the expression of SOX2 and BRACHURY and absence of
pluripotent associated genes and PAX6. Furthermore, we deter-
mined that the induction of CNPs from hPSC involves the com-
bination of canonical Wnt, IGF1, and FGF8 pathways.
Our study has identified the mechanisms by which CHIR is
able to mediate induction of CNPs from hPSC. Previous studies
have suggested that CHIR activates canonical Wnt signaling,
which caudalizes hPSC-derived neural progenitors [9, 38]. This
hypothesis is based on the observation that hPSC neural induc-
tion via SMAD inhibition only generates forebrain neural pro-
genitors and thus, the caudal shift mediated by CHIR treatment
corresponds to spatial positions of neural crest and floor plate
cells along the embryonic A-P neural tube axis. Consistent with
this theory, our expression data of day 4 CHIR-treated hESC,
that is CNPs, do show a significant increase in the hindbrain
marker, GBX2, as well as the mesoderm progenitor marker,
BRACHYURY. This expression profile may be somewhat similar
to the bipotential axial stem cells found in the caudal regions
of amniote (avian and mouse) embryos [4]. Both Sox2 and Bra-
chyury are expressed in these cells, which are located in the
regions adjacent to the primitive streak within the caudal neu-
ral plate [5]. It is proposed that Wnt3a signaling combined
with BMP repression via NOG released from the node induces
Sox2 expression in the axial stem cells to drive neural fate.
Whereas, axial cells migrating through the primitive streak are
Figure 5. Caudal neural progenitor-derived neural crest progenitors differentiate into peripheral neurons and Schwann cells. (A): Immu-
nocytochemistry analysis of condition SB/CHIR-BMP-Y27 at day 18. TUJ1, PRPH, BRN3A, and ISLET1. (B): Diagram of culture conditions.
(C): Immunocytochemistry analysis for Schwann cell, S100b, and P75. (D): Differentiation of neural crest progenitors into adipocytes,
chondrocytes, and osteocytes, cells stained with oil red O, alcian blue, and alizarin red, respectively (scale bar5 100 mm). Scale
bars5 Tuj1, BRN3A, and ISLET15 500 mm, Peripherin5 100 mm, S100b/P755 50 mm, all insets5 20 mm.
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less exposed to Wnt signals, and this mediates both the down-
regulation of Sox2 and a corresponding increase in Tbx6
expression, thereby inducing mesoderm fate [4]. In our study,
the CNPs show a bias to differentiate toward neural lineages
rather than mesoderm. The disparity in differentiation potential
between embryonic axial stem cells and hPSC-derived CNPs
may be due to differences in the levels of canonical Wnt sig-
naling and/or the activation of other signaling pathways.
In our studies, the signaling pathways required to derive
CNPs from hPSC were determined. We found that CHIR treat-
ment of hPSC could be replaced by combined treatment with
extrinsic factors Wnt3a, IGF1, and FGF8. Indeed, canonical Wnt
signaling inhibits GSK3b [39]. Similarly, FGF8 and IGF1 also inhibit
GSK3b via Mek/Erk-p90RSK and PI3K/Akt pathways, respectively
[40–42]. The PI3K/Akt pathway also represses SMAD2/3 signaling
[37]. The involvement of these signaling pathways in deriving
CNPs was supported by our findings showing that small molecule
inhibitors of Erk/Mek and PI3K/Akt repressed induction of CNPs
and subsequently the neural crest and floor plate derivatives.
Furthermore, previous reports have shown that Gsk3b inhibition
together with Activin signaling promotes hPSC differentiation
toward mesoderm via the canonical WNT and SMAD2/3 path-
ways [37]. Since SB is an inhibitor of SMAD2/3 signaling, this
blocks hPSC differentiation to mesoderm. SMAD2/3 inhibition
also induces expression of rostral neuroepithelial markers; how-
ever, this is prevented in our system because of the simultaneous
inhibition of GSK3b signaling. Therefore, in essence, dual inhibi-
tion of GSK3b and SMAD2/3 pathways induces hPSC to differenti-
ate directly to CNPs, whilst transiently repressing lineage
determination toward mesoderm and neural fates. It is during
this early caudal state prior to PAX6 expression that exposure to
morphogens, such as BMP and SHH, will direct CNP fate to neural
crest/roof plate or floor plate lineages, respectively. Whereas,
once CNPs have differentiated to PAX61 caudal neuroepithelial
cells, activation of BMP and SHH signaling will induce their differ-
entiation to dorsal and ventral neural progenitors, respectively.
Figure 6. Transplantation of caudal neural progenitor derived neural crest progenitors in ovo and in explant cultures of quail gut tissue.
(A–F): SB/CHIR-BMP group and (G) SB/CHIR-FGF group. (A, B, E, G): Transverse section; (C) sagittal slice; (D, F) whole mount. (A): BMP
spheres were implanted next to trunk NT at E2 and grown to E5. Cells show extensive hemisegmental migration along endogenous NC
pathways. (B): GFP1/SOX101 cells can be found within endogenous sympathetic chain regions. GFP1/P751 cells can also be identified
and GFP cells identified in DRG and in nerve fiber tracts. (C): BMP spheres were implanted next to NT at vagal level (Somite 3) at E1.5
(9 somite stage) and analyzed at E4.5, showing hemisegmental streams toward foregut. Arrow indicates site of implanted sphere at
E1.5. (D): BMP spheres were implanted next to NT at E2 and analyzed at E7, GFP cells migrating with host peripheral axons in flank der-
mis. (E): BMP spheres were implanted into dorsal NT/NC-ablated embryos at E2 and analyzed at E5. In the absence of host NC and host
DRG, cells from BMP-treated spheres maintain migration potential. (F): Cells of BMP spheres migrate into gut when placed abutting E4
quail mid/hindgut and grown for 7 days in CAM graft. Arrow indicates a chain of migrating GFP1 cells in the gut wall. (G): Control FGF
spheres implanted next to NT do not migrate but forms neural tube-like structures, with neurons and axons accompanying host axons.
Markers: HuC/D5 neuron-specific marker, Sox10, p755NC markers, E/C85 avian-specific axon marker, NF5 neurofilament (axon)
marker. Scale bars5 (A–E), (G)5 200 mm, (E) and (F) insets5 100 mm, (F)5 1 mm. Abbreviations: DRG, dorsal root ganglion; FG, fore-
gut; GFP, green fluorescent protein; NCC, neural crest cells; nch, notochord; NT, neural tube; Sy, sympathetic chain.
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Consistent with our findings, previous studies also showed
that neural crest induction occurred prior to and at the
expense of rosette-forming CNS neuroepithelial cells [43, 44].
Studer and colleagues described a method for inducing neural
crest and melanocyte precursors from hPSC using combined
inhibition of BMP and TGFb signaling for 2–3 days followed by
CHIR treatment for another 8 days [43]. Specification of neural
crest to melanocytes was induced by exposure of BMP4 and
endothelin3 during CHIR treatment. Dalton and colleagues also
described a similar protocol for generating neural crest, which
involved activation of the canonical Wnt pathway and SMAD
inhibition [44]. Although the methodologies are very similar,
our study identified a specific progenitor stage during hPSCs
neural crest induction, which is the same progenitor type for
induction to floor plate and neuroepithelial lineages. What
determines CNP fate to dorsal, ventral, or intermediate cell
types depends on the subsequent extrinsic signaling factors.
CONCLUSIONS
In summary, this study has identified and defined an early
CNP state that mimics the embryonic caudal neural plate
region and is pivotal for cell fate toward major progenitor lin-
eages of the central and peripheral nervous system. Overall,
these studies reveal the key players and pathways that under-
pin neurogenesis and stem cell fate.
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